These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 31147782)

  • 21. Expression of inhibitory markers is increased on effector memory T cells during hepatitis C virus/HIV coinfection as compared to hepatitis C virus or HIV monoinfection.
    Saha B; Choudhary MC; Sarin SK
    AIDS; 2013 Sep; 27(14):2191-200. PubMed ID: 23820090
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HCV coinfection contributes to HIV pathogenesis by increasing immune exhaustion in CD8 T-cells.
    Rallón N; García M; García-Samaniego J; Rodríguez N; Cabello A; Restrepo C; Álvarez B; García R; Górgolas M; Benito JM
    PLoS One; 2017; 12(3):e0173943. PubMed ID: 28323897
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dominant enrichment of phenotypically activated CD38(+) HLA-DR(+) CD8(+) T cells, rather than CD38(+) HLA-DR(+) CD4(+) T cells, in HIV/HCV coinfected patients on antiretroviral therapy.
    d'Ettorre G; Ceccarelli G; Serafino S; Giustini N; Cavallari EN; Bianchi L; Pavone P; Bellelli V; Turriziani O; Antonelli G; Stroffolini T; Vullo V
    J Med Virol; 2016 Aug; 88(8):1347-56. PubMed ID: 26765625
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship between hepatitis C virus (HCV) and insulin resistance, endothelial perturbation, and platelet activation in HIV-HCV-coinfected patients under highly active antiretroviral treatment.
    de Larrañaga GF; Wingeyer SD; Puga LM; Alonso BS; Benetucci JA
    Eur J Clin Microbiol Infect Dis; 2006 Feb; 25(2):98-103. PubMed ID: 16477441
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of co-infection by hepatitis C virus on immunological and virological response to antiretroviral therapy in HIV-positive patients.
    Portocarrero Nuñez JA; Gonzalez-Garcia J; Berenguer J; Gallego MJV; Loyarte JAI; Metola L; Bernal E; Navarro G; Del Amo J; Jarrín I;
    Medicine (Baltimore); 2018 Sep; 97(38):e12238. PubMed ID: 30235668
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cell-Associated HIV-1 Unspliced-to-Multiply-Spliced RNA Ratio at 12 Weeks of ART Predicts Immune Reconstitution on Therapy.
    Scherpenisse M; Kootstra NA; Bakker M; Berkhout B; Pasternak AO
    mBio; 2021 Mar; 12(2):. PubMed ID: 33688002
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HCV coinfection of the HIV-infected patients with discordant CD4
    Shmagel KV; Korolevskaya LB; Saidakova EV; Shmagel NG; Chereshnev VA; Margolis L; Anthony D; Lederman M
    Dokl Biol Sci; 2017 Nov; 477(1):244-247. PubMed ID: 29299802
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Longitudinal analysis of immune reconstitution and metabolic changes in women living with HIV: A real-world observational study.
    Wang X; Xiao J; Zhang L; Liu Y; Chen N; Deng M; Song C; Liu T; Zhang Y; Zhao H
    Chin Med J (Engl); 2023 Sep; 136(18):2168-2177. PubMed ID: 37580056
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determinants of immunological and virological responses to antiretroviral therapy amongst HIV-infected adults in central Argentina: negative influence of hepatitis C infection.
    Farías AA; Kremer LE; Allende L; Díaz Mdel P; Pisano MB; Contigiani MS; Ré VE
    Trans R Soc Trop Med Hyg; 2013 Jul; 107(7):432-7. PubMed ID: 23761392
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Food insecurity may lead to incomplete HIV viral suppression and less immune reconstitution among HIV/hepatitis C virus-coinfected people.
    Aibibula W; Cox J; Hamelin AM; Moodie E; Naimi AI; McLinden T; Klein MB; Brassard P
    HIV Med; 2018 Feb; 19(2):123-131. PubMed ID: 29094807
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HBV, HCV, and HBV/HCV co-infection among HIV-positive patients in Hunan province, China: Regimen selection, hepatotoxicity, and antiretroviral therapy outcome.
    Su S; Fairley CK; Sasadeusz J; He J; Wei X; Zeng H; Jing J; Mao L; Chen X; Zhang L
    J Med Virol; 2018 Mar; 90(3):518-525. PubMed ID: 29091279
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis C infection on immune recovery in HIV-positive patients on successful HAART: the role of genotype 3.
    Seminari E; Tinelli C; Ravasi G; Ripamonti D; Ladisa N; Marino N; Sighinolfi L; Mondello P; Migliorino M; Carosi G; Maserati R;
    Curr HIV Res; 2010 Apr; 8(3):186-93. PubMed ID: 20163342
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Higher Activation in CD4(+) T Cells But Similar Viral Control Among HIV/Hepatitis C Virus-Coinfected Patients on a Simplification Monotherapy.
    BenMarzouk-Hidalgo OJ; Torres-Cornejo A; Gutierrez-Valencia A; Ruiz-Valderas R; Viciana P; López-Cortés LF
    AIDS Res Hum Retroviruses; 2016 Jan; 32(1):6-11. PubMed ID: 26414169
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coinfection with hepatitis viruses and outcome of initial antiretroviral regimens in previously naive HIV-infected subjects.
    De Luca A; Bugarini R; Lepri AC; Puoti M; Girardi E; Antinori A; Poggio A; Pagano G; Tositti G; Cadeo G; Macor A; Toti M; D'Arminio Monforte A;
    Arch Intern Med; 2002 Oct; 162(18):2125-32. PubMed ID: 12374521
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of hepatitis C on HIV progression in adults with alcohol problems.
    Cheng DM; Nunes D; Libman H; Vidaver J; Alperen JK; Saitz R; Samet JH
    Alcohol Clin Exp Res; 2007 May; 31(5):829-36. PubMed ID: 17403066
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monocyte activation in HIV/HCV coinfection correlates with cognitive impairment.
    Rempel H; Sun B; Calosing C; Abadjian L; Monto A; Pulliam L
    PLoS One; 2013; 8(2):e55776. PubMed ID: 23437063
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Special considerations in the initiation and management of antiretroviral therapy in individuals coinfected with HIV and hepatitis C.
    Braitstein P; Palepu A; Dieterich D; Benhamou Y; Montaner JS
    AIDS; 2004 Nov; 18(17):2221-34. PubMed ID: 15577534
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Managing symptomatic drug-induced liver injury in HIV-hepatitis C virus-coinfected patients: a role for interferon.
    McGovern BH; Birch C; Zaman MT; Bica I; Stone D; Quirk JR; Davis B; Zachary K; Basgoz N; Graeme-Cook F; Gandhi RT
    Clin Infect Dis; 2007 Nov; 45(10):1386-92. PubMed ID: 17968840
    [TBL] [Abstract][Full Text] [Related]  

  • 39. During Hepatitis C Virus (HCV) Infection and HCV-HIV Coinfection, an Elevated Plasma Level of Autotaxin Is Associated With Lysophosphatidic Acid and Markers of Immune Activation That Normalize During Interferon-Free HCV Therapy.
    Kostadinova L; Shive CL; Judge C; Zebrowski E; Compan A; Rife K; Hirsch A; Falck-Ytter Y; Schlatzer DM; Li X; Chance MR; Rodriguez B; Popkin DL; Anthony DD
    J Infect Dis; 2016 Nov; 214(9):1438-1448. PubMed ID: 27540113
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Persistently low CD4 cell counts are associated with hepatic events in HCV/HIV coinfected patients: data from the national free antiretroviral treatment program of China.
    Lin W; Zhong H; Wen C; He Y; Zheng X; Li H; Chen X; He H; Chen J; Chen L; Liu C; Tang X; Cai W; Li L
    Chin Med J (Engl); 2022 Nov; 135(22):2699-2705. PubMed ID: 36574222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.